Biopharmaceuticals
HIV/AIDS
FDA
News Release - July 4, 2018
Theratechnologies Submits Novel Single-Vial Formulation of EGRIFTA(R) (Tesamorelin for Injection) for FDA Approval
Source: Theratechnologies
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.